September 30, 2025
Dr Sanjay Batra Discusses Juvasonic on The Technology of Beauty Podcast
Overview We’re thrilled to announce that Dr. Sanjay Batra, CEO of Juvasonic® and a driving…
FDA Registered Facility #3037407231.
Class 1 medical device with ARTG inclusion pending.
Patented Delivery Technology.
Sanjay BATRA. U.S. App. No. 63/711,853
APPARATUS AND METHOD FOR INTRADERMAL DELIVERY OF ACTIVES FOLLOWING PRECONDITIONING OF SKIN.
Sanjay BATRA. U.S. App. No. No. 63/737,981
METHOD AND APPARATUS FOR REDUCTION, REMOVAL OR DISPERSION OF DERMAL FILLER AGGREGATES.
The information provided in connection with these products is for general educational purposes only and is not intended to replace professional medical advice. In Australia and New Zealand, these products are supplied in accordance with applicable regulatory requirements. This product is not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.
